Clinical Trials Browser

Phase 2 × Neurofibroma, Plexiform × Imatinib Mesylate × Clear all

NCT03688568 2021-02-12

Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Phase 2 Withdrawn

Neurofibroma, Plexiform

NCT02177825 2019-04-08

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

Phase 2 Terminated

Neurofibroma, Plexiform